• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基质金属蛋白酶血红素结合蛋白结构域在细胞迁移中的作用。

Role of the hemopexin domain of matrix metalloproteinases in cell migration.

作者信息

Dufour Antoine, Sampson Nicole S, Zucker Stanley, Cao Jian

机构信息

Department of Chemistry, Stony Brook University, Stony Brook, New York 11794, USA.

出版信息

J Cell Physiol. 2008 Dec;217(3):643-51. doi: 10.1002/jcp.21535.

DOI:10.1002/jcp.21535
PMID:18636552
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2574584/
Abstract

The biological functions of matrix metalloproteinases (MMPs) extend beyond extracellular matrix degradation. Non-proteolytic activities of MMPs are just beginning to be understood. Herein, we evaluated the role of proMMPs in cell migration. Employing a Transwell chamber migration assay, we demonstrated that transfection of COS-1 cells with various proMMP cDNAs resulted in enhancement of cell migration. Latent MMP-2 and MMP-9 enhanced cell migration to a greater extent than latent MMP-1, -3, -11 and -28. To examine if proteolytic activity is required for MMP-enhanced cell migration, three experimental approaches, including fluorogenic substrate degradation assay, transfection of cells with catalytically inactive mutant MMP cDNAs, and addition of hydroxamic acid-derived MMP inhibitors, were employed. We demonstrated that the proteolytic activities of MMPs are not required for MMP-induced cell migration. To explore the mechanism underlying MMP-enhanced cell migration, structure-function relationship of MMP-9 on cell migration was evaluated. By using a domain swapping approach, we demonstrated that the hemopexin domain of proMMP-9 plays an important role in cell migration when examined by a transwell chamber assay and by a phagokinetic migration assay. TIMP-1, which interacts with the hemopexin domain of proMMP-9, inhibited cell migration, whereas TIMP-2 had no effect. Employing small molecular inhibitors, MAPK and PI3K pathways were found to be involved in MMP-9-mediated cell migration. In conclusion, we demonstrated that MMPs utilize a non-proteolytic mechanism to enhance epithelial cell migration. We propose that hemopexin homodimer formation is required for the full cell migratory function of proMMP-9.

摘要

基质金属蛋白酶(MMPs)的生物学功能不仅限于细胞外基质降解。MMPs的非蛋白水解活性才刚刚开始被了解。在此,我们评估了前MMPs在细胞迁移中的作用。采用Transwell小室迁移试验,我们证明用各种前MMP cDNA转染COS-1细胞会导致细胞迁移增强。潜伏性MMP-2和MMP-9比潜伏性MMP-1、-3、-11和-28更能增强细胞迁移。为了研究MMP增强细胞迁移是否需要蛋白水解活性,我们采用了三种实验方法,包括荧光底物降解试验、用催化失活的突变体MMP cDNA转染细胞以及添加异羟肟酸衍生的MMP抑制剂。我们证明MMP诱导的细胞迁移不需要MMPs的蛋白水解活性。为了探索MMP增强细胞迁移的潜在机制,我们评估了MMP-9在细胞迁移中的结构-功能关系。通过使用结构域交换方法,我们证明在前MMP-9通过Transwell小室试验和吞噬动力学迁移试验检测时,其血色素结合蛋白结构域在细胞迁移中起重要作用。与前MMP-9的血色素结合蛋白结构域相互作用的TIMP-1抑制细胞迁移,而TIMP-2没有作用。使用小分子抑制剂,发现MAPK和PI3K途径参与MMP-9介导的细胞迁移。总之,我们证明MMPs利用非蛋白水解机制增强上皮细胞迁移。我们提出前MMP-9的完整细胞迁移功能需要血色素结合蛋白同二聚体的形成。

相似文献

1
Role of the hemopexin domain of matrix metalloproteinases in cell migration.基质金属蛋白酶血红素结合蛋白结构域在细胞迁移中的作用。
J Cell Physiol. 2008 Dec;217(3):643-51. doi: 10.1002/jcp.21535.
2
Targeting the Hemopexin-like Domain of Latent Matrix Metalloproteinase-9 (proMMP-9) with a Small Molecule Inhibitor Prevents the Formation of Focal Adhesion Junctions.用小分子抑制剂靶向潜伏基质金属蛋白酶-9(proMMP-9)的血红素结合蛋白样结构域可防止粘着斑连接的形成。
ACS Chem Biol. 2017 Nov 17;12(11):2788-2803. doi: 10.1021/acschembio.7b00758. Epub 2017 Oct 10.
3
Role of matrix metalloproteinase-9 dimers in cell migration: design of inhibitory peptides.基质金属蛋白酶-9 二聚体在细胞迁移中的作用:抑制肽的设计。
J Biol Chem. 2010 Nov 12;285(46):35944-56. doi: 10.1074/jbc.M109.091769. Epub 2010 Sep 13.
4
Small-molecule anticancer compounds selectively target the hemopexin domain of matrix metalloproteinase-9.小分子抗癌化合物选择性地针对基质金属蛋白酶-9 的血红素结合蛋白结构域。
Cancer Res. 2011 Jul 15;71(14):4977-88. doi: 10.1158/0008-5472.CAN-10-4552. Epub 2011 Jun 6.
5
Peptide from the C-terminal domain of tissue inhibitor of matrix metalloproteinases-2 (TIMP-2) inhibits membrane activation of matrix metalloproteinase-2 (MMP-2).组织金属蛋白酶抑制剂-2(TIMP-2)C 端结构域的肽抑制基质金属蛋白酶-2(MMP-2)的膜激活。
Matrix Biol. 2011 Sep;30(7-8):404-12. doi: 10.1016/j.matbio.2011.07.001. Epub 2011 Aug 4.
6
Distinct roles for the catalytic and hemopexin domains of membrane type 1-matrix metalloproteinase in substrate degradation and cell migration.膜型1-基质金属蛋白酶的催化结构域和血红素结合蛋白结构域在底物降解和细胞迁移中的不同作用。
J Biol Chem. 2004 Apr 2;279(14):14129-39. doi: 10.1074/jbc.M312120200. Epub 2004 Jan 16.
7
MMP-9-hemopexin domain hampers adhesion and migration of colorectal cancer cells.基质金属蛋白酶-9血色素结合蛋白结构域抑制结肠癌细胞的黏附和迁移。
Int J Oncol. 2007 Apr;30(4):985-92. doi: 10.3892/ijo.30.4.985.
8
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in joint fluid of the patients with loose artificial hip joints.人工髋关节松动患者关节液中的基质金属蛋白酶和金属蛋白酶组织抑制剂
J Biomed Mater Res. 1999 Jun 5;45(3):175-83. doi: 10.1002/(sici)1097-4636(19990605)45:3<175::aid-jbm3>3.0.co;2-9.
9
Proteolytic action of kallikrein-related peptidase 7 produces unique active matrix metalloproteinase-9 lacking the C-terminal hemopexin domains.激肽释放酶相关肽酶7的蛋白水解作用产生了独特的、缺乏C末端血红素结合蛋白结构域的活性基质金属蛋白酶-9。
Biochim Biophys Acta. 2011 Aug;1813(8):1525-31. doi: 10.1016/j.bbamcr.2011.05.007. Epub 2011 May 17.
10
Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).金属蛋白酶组织抑制剂2(TIMP-2)的序列基序决定了前明胶酶A(proMMP-2)与膜型金属蛋白酶1(MT1-MMP)的结合及激活。
Biochem J. 2003 Jun 15;372(Pt 3):799-809. doi: 10.1042/BJ20021573.

引用本文的文献

1
Upregulation of MMP3 Promotes Cisplatin Resistance in Ovarian Cancer.基质金属蛋白酶3的上调促进卵巢癌顺铂耐药
Int J Mol Sci. 2025 Apr 24;26(9):4012. doi: 10.3390/ijms26094012.
2
Matrix Metalloproteinases in Glioma: Drivers of Invasion and Therapeutic Targets.胶质瘤中的基质金属蛋白酶:侵袭驱动因素与治疗靶点
BioTech (Basel). 2025 Apr 15;14(2):28. doi: 10.3390/biotech14020028.
3
The Effect of Tissue Inhibitor of Metalloproteinases on Scar Formation after Spinal Cord Injury.组织金属蛋白酶抑制剂对脊髓损伤后瘢痕形成的影响。
Cells. 2024 Sep 14;13(18):1547. doi: 10.3390/cells13181547.
4
Cystatin C as an adjunct to HbA1c may prove useful in predicting the development of diabetic complications in children and adolescents with type 1 diabetes.胱抑素C作为糖化血红蛋白的辅助指标,可能有助于预测1型糖尿病儿童和青少年糖尿病并发症的发生。
J Diabetes Metab Disord. 2024 Apr 18;23(1):1251-1257. doi: 10.1007/s40200-024-01419-1. eCollection 2024 Jun.
5
Morquio A Syndrome: Identification of Differential Patterns of Molecular Pathway Interactions in Bone Lesions.黏多糖贮积症 A 型:骨病变中分子通路相互作用的差异模式鉴定。
Int J Mol Sci. 2024 Mar 12;25(6):3232. doi: 10.3390/ijms25063232.
6
CK2 inhibitor CX4945 inhibits collagen degradation of HaCaT human keratinocyte cells via attenuation of MMP-1 secretion.CK2 抑制剂 CX4945 通过抑制 MMP-1 的分泌来抑制 HaCaT 人角质形成细胞胶原的降解。
Mol Biol Rep. 2023 Nov;50(11):9691-9698. doi: 10.1007/s11033-023-08708-7. Epub 2023 Sep 2.
7
Investigation of target genes and potential mechanisms related to compound Xiao-ai-fei honey ointment based on network pharmacology and bioinformatics analysis.基于网络药理学和生物信息学分析的复方消癌肺蜜膏相关作用靶点及作用机制的研究。
Medicine (Baltimore). 2023 Aug 11;102(32):e34629. doi: 10.1097/MD.0000000000034629.
8
Matrix Metalloproteinases Inhibitors in Cancer Treatment: An Updated Review (2013-2023).基质金属蛋白酶抑制剂在癌症治疗中的应用:更新综述(2013-2023)。
Molecules. 2023 Jul 21;28(14):5567. doi: 10.3390/molecules28145567.
9
Matrix Metalloproteinase 9 Induced in Esophageal Squamous Cell Carcinoma Cells via Close Contact with Tumor-Associated Macrophages Contributes to Cancer Progression and Poor Prognosis.通过与肿瘤相关巨噬细胞密切接触在食管鳞状细胞癌细胞中诱导产生的基质金属蛋白酶9促进癌症进展并导致预后不良。
Cancers (Basel). 2023 May 30;15(11):2987. doi: 10.3390/cancers15112987.
10
Matrix metalloproteinases in coronary artery disease and myocardial infarction.基质金属蛋白酶与冠状动脉疾病和心肌梗死。
Basic Res Cardiol. 2023 May 9;118(1):18. doi: 10.1007/s00395-023-00987-2.

本文引用的文献

1
Insights into the structure and domain flexibility of full-length pro-matrix metalloproteinase-9/gelatinase B.全长前基质金属蛋白酶-9/明胶酶B的结构与结构域灵活性研究
Structure. 2007 Oct;15(10):1227-36. doi: 10.1016/j.str.2007.07.019.
2
Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases.基质金属蛋白酶抑制剂作为炎症和血管疾病的治疗方法。
Nat Rev Drug Discov. 2007 Jun;6(6):480-98. doi: 10.1038/nrd2308.
3
Epidermal growth factor and transforming growth factor-beta1 enhance HK-2 cell migration through a synergistic increase of matrix metalloproteinase and sustained activation of ERK signaling pathway.表皮生长因子和转化生长因子-β1通过协同增加基质金属蛋白酶和持续激活ERK信号通路来增强HK-2细胞迁移。
Exp Cell Res. 2007 Jul 1;313(11):2367-77. doi: 10.1016/j.yexcr.2007.03.022. Epub 2007 Mar 30.
4
MMP-9-hemopexin domain hampers adhesion and migration of colorectal cancer cells.基质金属蛋白酶-9血色素结合蛋白结构域抑制结肠癌细胞的黏附和迁移。
Int J Oncol. 2007 Apr;30(4):985-92. doi: 10.3892/ijo.30.4.985.
5
Intracellular targets of matrix metalloproteinase-2 in cardiac disease: rationale and therapeutic approaches.心脏病中基质金属蛋白酶-2的细胞内靶点:理论依据与治疗方法
Annu Rev Pharmacol Toxicol. 2007;47:211-42. doi: 10.1146/annurev.pharmtox.47.120505.105230.
6
Crystal structure of an active form of human MMP-1.人MMP-1活性形式的晶体结构
J Mol Biol. 2006 Sep 8;362(1):78-88. doi: 10.1016/j.jmb.2006.06.079. Epub 2006 Aug 4.
7
Human mast cell-derived gelatinase B (matrix metalloproteinase-9) is regulated by inflammatory cytokines: role in cell migration.人肥大细胞衍生的明胶酶B(基质金属蛋白酶-9)受炎性细胞因子调控:在细胞迁移中的作用
J Immunol. 2006 Aug 15;177(4):2638-50. doi: 10.4049/jimmunol.177.4.2638.
8
The hemopexin and O-glycosylated domains tune gelatinase B/MMP-9 bioavailability via inhibition and binding to cargo receptors.血红素结合蛋白和O-糖基化结构域通过抑制和结合货物受体来调节明胶酶B/基质金属蛋白酶-9的生物利用度。
J Biol Chem. 2006 Jul 7;281(27):18626-37. doi: 10.1074/jbc.M512308200. Epub 2006 May 3.
9
Costimulation of chemokine receptor signaling by matrix metalloproteinase-9 mediates enhanced migration of IFN-alpha dendritic cells.基质金属蛋白酶-9对趋化因子受体信号的共刺激介导了干扰素-α树突状细胞迁移的增强。
J Immunol. 2006 May 15;176(10):6022-33. doi: 10.4049/jimmunol.176.10.6022.
10
Structure and function of matrix metalloproteinases and TIMPs.基质金属蛋白酶和金属蛋白酶组织抑制因子的结构与功能
Cardiovasc Res. 2006 Feb 15;69(3):562-73. doi: 10.1016/j.cardiores.2005.12.002. Epub 2006 Jan 5.